Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta‐analysis

左旋西孟旦 医学 内科学 心脏病学 射血分数 心力衰竭 脑利钠肽 利钠肽 冲程容积 变向性 心室重构 置信区间
作者
Xia Wang,Xiaoxian X. Zhao,X Wang,Lu‐Ying Cao,Bin Lü,Zhi‐Hao Wang,Wei Zhang,Yun Ti,Ming Zhong
出处
期刊:Esc Heart Failure [Wiley]
被引量:2
标识
DOI:10.1002/ehf2.14714
摘要

Abstract Heart failure is the final stage of several cardiovascular diseases, and the key to effectively treating heart failure is to reverse or delay ventricular remodelling. Levosimendan is a novel inotropic and vasodilator agent used in heart failure, whereas the impact of levosimendan on ventricular remodelling is still unclear. This study aims to investigate the impact of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction. Electronic databases were searched to identify eligible studies. A total of 66 randomized controlled trials involving 7968 patients were included. Meta‐analysis results showed that levosimendan increased left ventricular ejection fraction [mean difference (MD) = 3.62, 95% confidence interval (CI) (2.88, 4.35), P < 0.00001] and stroke volume [MD = 6.59, 95% CI (3.22, 9.96), P = 0.0001] and significantly reduced left ventricular end‐systolic volume [standard mean difference (SMD) = −0.52, 95% CI (−0.67, −0.37), P < 0.00001], left ventricular end‐diastolic volume index [SMD = −1.24, 95% CI (−1.61, −0.86), P < 0.00001], and left ventricular end‐systolic volume index [SMD = −1.06, 95% CI (−1.43, −0.70), P < 0.00001]. In terms of biomarkers, levosimendan significantly reduced the level of brain natriuretic peptide [SMD = −1.08, 95% CI (−1.60, −0.56), P < 0.0001], N‐terminal pro‐brain natriuretic peptide [SMD = −0.99, 95% CI (−1.41, −0.56), P < 0.00001], and interleukin‐6 [SMD = −0.61, 95% CI (−0.86, −0.35), P < 0.00001]. Meanwhile, levosimendan may increase the incidence of hypotension [risk ratio (RR) = 1.24, 95% CI (1.12, 1.39), P < 0.0001], hypokalaemia [RR = 1.57, 95% CI (1.08, 2.28), P = 0.02], headache [RR = 1.89, 95% CI (1.50, 2.39), P < 0.00001], atrial fibrillation [RR = 1.31, 95% CI (1.12, 1.52), P = 0.0005], and premature ventricular complexes [RR = 1.86, 95% CI (1.27, 2.72), P = 0.001]. In addition, levosimendan reduced all‐cause mortality [RR = 0.83, 95% CI (0.74, 0.94), P = 0.002]. In conclusion, our study found that levosimendan might reverse ventricular remodelling when applied in patients with left ventricular systolic dysfunction, especially in patients undergoing cardiac surgery, decompensated heart failure, and septic shock.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
bkagyin应助zzz采纳,获得10
1秒前
fengyvan完成签到,获得积分10
1秒前
隐形曼青应助柒_l采纳,获得10
2秒前
无花果应助wang采纳,获得10
2秒前
叫我益达完成签到,获得积分10
2秒前
3秒前
欢呼问旋完成签到,获得积分10
4秒前
沉潜完成签到,获得积分10
4秒前
Orange应助yyy采纳,获得10
6秒前
6秒前
Hui发布了新的文献求助10
6秒前
陶醉的又夏完成签到 ,获得积分10
7秒前
今后应助J.采纳,获得10
7秒前
234完成签到,获得积分10
7秒前
单于青荷发布了新的文献求助10
7秒前
9秒前
AAA顺利毕业完成签到,获得积分10
9秒前
可爱的大白菜真实的钥匙完成签到 ,获得积分10
10秒前
领导范儿应助凭亿近人采纳,获得10
10秒前
刘婧完成签到,获得积分10
11秒前
Wacky发布了新的文献求助10
12秒前
sk夏冰完成签到 ,获得积分10
12秒前
戚雅柔完成签到 ,获得积分10
12秒前
Lunanar完成签到,获得积分10
12秒前
whooer发布了新的文献求助10
12秒前
单于青荷完成签到,获得积分10
14秒前
柒_l发布了新的文献求助10
15秒前
褚恋风完成签到 ,获得积分10
15秒前
15秒前
FashionBoy应助AAA顺利毕业采纳,获得10
17秒前
18秒前
神勇的向薇完成签到,获得积分10
18秒前
nanheng完成签到,获得积分10
19秒前
20秒前
橙子发布了新的文献求助10
20秒前
达不刘完成签到,获得积分10
20秒前
SciGPT应助褚恋风采纳,获得10
20秒前
22秒前
A2QD完成签到,获得积分10
22秒前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
Indomethacinのヒトにおける経皮吸収 400
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 370
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
Aktuelle Entwicklungen in der linguistischen Forschung 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3991462
求助须知:如何正确求助?哪些是违规求助? 3532737
关于积分的说明 11258839
捐赠科研通 3271760
什么是DOI,文献DOI怎么找? 1805565
邀请新用户注册赠送积分活动 882545
科研通“疑难数据库(出版商)”最低求助积分说明 809344